Creve Coeur, MO, United States of America

Michael J Guiliani


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael J. Guiliani

Introduction

Michael J. Guiliani, based in Creve Coeur, MO, is an accomplished inventor with a focus on pharmaceutical innovations. With two patents to his name, his work primarily addresses the challenges within pain management and drug delivery systems.

Latest Patents

Guiliani's latest patents showcase his dedication to advancing pharmaceutical compositions. The first patent is for a "Gastric retentive extended release pharmaceutical composition," which includes an opioid and an additional active pharmaceutical ingredient. This innovation is designed to exhibit gastric retentive properties, allowing for a more consistent pharmacokinetic profile regardless of the subject's fasted or fed state.

The second patent, titled "Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia," provides a groundbreaking approach to pain relief. This extended release formulation not only offers a rapid onset of analgesia but also minimizes the risk of acetaminophen-induced hepatic damage, making it a safer option for patients requiring pain management.

Career Highlights

Michael J. Guiliani is currently associated with Mallinckrodt Inc., a leading global specialty pharmaceutical company. His contributions to the field of pain management through innovative drug formulations have positioned him as a notable figure in pharmaceutical research and development.

Collaborations

Throughout his career, Guiliani has collaborated with talented professionals such as Krishna Devarakonda and Vishal K. Gupta. These partnerships have enhanced his research efforts, contributing to the success of his innovative projects and patents.

Conclusion

Michael J. Guiliani's work exemplifies the intersection of innovation and healthcare. His patents reflect a commitment to improving patient outcomes through tailored pharmaceutical compositions. As he continues his work at Mallinckrodt Inc., Guiliani remains a significant contributor to advancements in pain management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…